Clinical Trials Directory

Trials / Completed

CompletedNCT06806696

SARS-COV-2 VARIANTS' EFFECT ON PREGNANCY AND LONG-TERM OUTCOMES AMONG PREGNANT WOMEN AND THEIR NEWBORNS IN ESTONIA

Status
Completed
Phase
Study type
Observational
Enrollment
60,739 (actual)
Sponsor
University of Tartu · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The main aim of the study is to describe the possible impacts of SARS-CoV-2 and its various genotypes on pregnancy and long-term outcomes among pregnant women and their newborns in Estonia.

Detailed description

All the pregnant women in Estonia who conceived and gave birth between February 27, 2020, and March 1, 2023 were included in the study. Pregnant women will be divided into 2 groups: 1. pregnant women who were diagnosed with COVID-19 during the study period, along with their newborns; 2. control group: pregnant women who did not have COVID-19 during pregnancy, along with their newborns. The following data is collected for each subject: prior vaccination, previous COVID-19 infection, underlying diseases/conditions, hospitalization, need for intensive care, need for mechanical ventilation and/or oxygen therapy, death cases, post-COVID-19 symptoms, pregnancy course and outcomes, possible virus transmission from mother to child, and the newborn's condition or accompanying health issues

Conditions

Interventions

TypeNameDescription
OTHERCOVID-19 infectionCOVID-19 diagnosis in the health database

Timeline

Start date
2020-02-27
Primary completion
2023-03-01
Completion
2023-03-01
First posted
2025-02-04
Last updated
2025-02-04

Locations

1 site across 1 country: Estonia

Source: ClinicalTrials.gov record NCT06806696. Inclusion in this directory is not an endorsement.